The BMRN chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the BMRN chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The BMRN stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View BMRN Detailed Price Forecast - CNN Money||View BMRN Detailed Summary - Google Finance|
|View BMRN Detailed Summary - Yahoo! Finance||View BMRN Stock Research & Analysis - Zacks.com|
|View BMRN Trends & Analysis - Trade-Ideas||View BMRN Major Holders - Barrons|
|View BMRN Call Transcripts - NASDAQ||View BMRN Breaking News & Analysis - Seeking Alpha|
|View BMRN Annual Report - CompanySpotlight.com||View BMRN OTC Short Report - OTCShortReport.com|
|View BMRN Fundamentals - TradeKing||View BMRN SEC Filings - Bar Chart|
|View Historical Prices for BMRN - The WSJ||View Performance/Total Return for BMRN - Morningstar|
|View the Analyst Estimates for BMRN - MarketWatch||View the Earnings History for BMRN - CNBC|
|View the BMRN Earnings - StockMarketWatch||View BMRN Buy or Sell Recommendations - MacroAxis|
|View the BMRN Bullish Patterns - American Bulls||View BMRN Short Pain Metrics - ShortPainBot.com|
|View BMRN Stock Mentions - StockTwits||View BMRN Stock Mentions - PennyStockTweets|
|View BMRN Stock Mentions - Twitter||View BMRN Investment Forum News - Investor Hub|
|View BMRN Stock Mentions - Yahoo! Message Board||View BMRN Stock Mentions - Seeking Alpha|
|View Insider Transactions for BMRN - SECform4.com||View Insider Transactions for BMRN - Insider Cow|
|View BMRN Major Holdings Summary - CNBC||View Insider Disclosure for BMRN - OTC Markets|
|View Insider Transactions for BMRN - Yahoo! Finance||View Institutional Holdings for BMRN - NASDAQ|
|View BMRN Stock Insight & Charts - FinViz.com||View BMRN Investment Charts - StockCharts.com|
|View BMRN Stock Overview & Charts - BarChart||View BMRN User Generated Charts - Trading View|
BioMarin to Host Second Quarter 2018 Financial Results Conference Call and Webcast on Thursday, August 2 at 4:30pm ET
Posted on Wednesday July 11, 2018
SAN RAFAEL, Calif. , July 11, 2018 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Jean-Jacques Bienaimé, Chairman and Chief Executive Officer of BioMarin, will host a ...
Gene Therapy: BioMarin, Spark Can Both Win Treating Hemophilia
Posted on Monday July 09, 2018
Gene therapy has been hailed as a potential breakthrough treatment for many diseases, and today Credit Suisse's Martin Auster takes a look at its future for hemophilia treatment. Auster writes that gene therapy could become a "foundational approach in hemophilia management," with important data points due out this summer from Spark Therapeutics (ONCE) Pfizer (PFE) that will "incrementally evolve the landscape." He writes that there are signs of high patient demand for new treatments, and that gene therapy could be a more cost-efficient way to improve poor outcomes for hemophilia patients in the emerging markets. The stakes are still high: Auster believes that if issues arise, "uptake would ultimately disappoint greatly," but if long-term safety and durability is established, he expects "broad adoption of gene therapy given convenience and economic benefits." Ultimately, he believes that in this environment, the binary debate of Spark versus BioMarin Pharmaceuticals (BMRN) isn't the full picture.
BioMarin Partners with Believe Limited for 'Breaking Through!' Musical Theater Intensive
Posted on Monday July 09, 2018
SAN RAFAEL, Calif., July 9, 2018 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (BMRN) today announced an exclusive partnership with Believe Limited to produce the 'Breaking Through!' musical theater intensive. The first-of-its-kind program is a three-day music workshop for the bleeding disorders community and is designed to provide young adults with powerful education on the healing and therapeutic power of the arts and self-expression. The musical workshop, directed by hemophilia advocate and Believe Limited CEO Patrick James Lynch, will be held from November 9 – November 12, 2018 and will culminate in a Broadway-style performance for local bleeding disorder community members, family and friends.
Sarepta's DMD Portfolio Solid, Sole Drug Dependence Concerns
Posted on Thursday July 05, 2018
Sarepta Therapeutics' (SRPT) DMD drug sales are rising and pipeline candidates are progressing well. However, dependence on a single product for near-term growth is a concern.